Marc Pfister

5.2k total citations
184 papers, 3.9k citations indexed

About

Marc Pfister is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Surgery. According to data from OpenAlex, Marc Pfister has authored 184 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pediatrics, Perinatology and Child Health, 32 papers in Pharmacology and 28 papers in Surgery. Recurrent topics in Marc Pfister's work include Pharmaceutical studies and practices (28 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Diabetes Treatment and Management (16 papers). Marc Pfister is often cited by papers focused on Pharmaceutical studies and practices (28 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Diabetes Treatment and Management (16 papers). Marc Pfister collaborates with scholars based in Switzerland, United States and Germany. Marc Pfister's co-authors include David W. Boulton, David M. Kornhauser, Bernard J. Komoroski, N. Vachharajani, Sreeneeranj Kasichayanula, Frank LaCreta, Feng Yan, Gilbert Koch, Mélanie Wilbaux and Xiaoni Liu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Marc Pfister

174 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Pfister Switzerland	33	1.3k	939	922	600	600	184	3.9k
Suodi Zhai China	32	778 0.6×	490 0.5×	772 0.8×	608 1.0×	260 0.4×	181	3.5k
In‐Jin Jang South Korea	40	571 0.4×	751 0.8×	1.5k 1.6×	808 1.3×	777 1.3×	306	5.9k
Kyung‐Sang Yu South Korea	32	609 0.5×	599 0.6×	918 1.0×	612 1.0×	597 1.0×	333	4.5k
Thomas Marbury United States	41	1.1k 0.8×	619 0.7×	946 1.0×	627 1.0×	367 0.6×	217	5.9k
Ferruccio Ceriotti Italy	42	825 0.6×	775 0.8×	626 0.7×	137 0.2×	258 0.4×	232	6.1k
Anders Åsberg Norway	39	622 0.5×	1.6k 1.7×	462 0.5×	354 0.6×	940 1.6×	251	5.9k
Paul Keown Canada	48	793 0.6×	2.8k 3.0×	1.1k 1.2×	539 0.9×	1.2k 2.1×	249	8.4k
Susan Hutfless United States	40	885 0.7×	2.1k 2.2×	736 0.8×	158 0.3×	240 0.4×	142	5.5k
F. Holleman Netherlands	33	2.1k 1.5×	1.3k 1.3×	1.0k 1.1×	130 0.2×	196 0.3×	114	5.2k
Jan G. Zijlstra Netherlands	40	462 0.3×	782 0.8×	1.2k 1.3×	342 0.6×	264 0.4×	255	6.0k

Countries citing papers authored by Marc Pfister

Since Specialization

Citations

This map shows the geographic impact of Marc Pfister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pfister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pfister more than expected).

Fields of papers citing papers by Marc Pfister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pfister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pfister. The network helps show where Marc Pfister may publish in the future.

Co-authorship network of co-authors of Marc Pfister

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pfister. A scholar is included among the top collaborators of Marc Pfister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pfister. Marc Pfister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butscheid, Yulia, Pascal M. Frey, Marc Pfister, et al.. (2025). Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study. Journal of Antimicrobial Chemotherapy. 80(7). 1837–1848.

Welzel, Tatjana, Andrew Atkinson, Verena Gotta, et al.. (2024). Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases. Pediatric Rheumatology. 22(1). 5–5. 3 indexed citations

Hofmann, Daniela, Michael Buettcher, Goonaseelan Pillai, et al.. (2024). Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire. Drugs in R&D. 24(2). 331–340. 1 indexed citations

Buettcher, Michael, Jörg Huwyler, John van den Anker, et al.. (2024). Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics. 16(9). 1186–1186.

Rodieux, Frédérique, Victoria C. Ziesenitz, Andrew Atkinson, et al.. (2024). Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study. The Journal of Clinical Pharmacology. 64(7). 810–819. 1 indexed citations

Koch, Gilbert, et al.. (2024). Computing optimal drug dosing regarding efficacy and safety: the enhanced OptiDose method in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 919–934. 2 indexed citations

Krause, Andreas, et al.. (2023). Modeling time‐delayed concentration‐QT effects with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5a₁ receptor) antagonist. Pharmacology Research & Perspectives. 11(4). e01112–e01112. 2 indexed citations

Burckhardt, Marie‐Anne, et al.. (2023). New model of glucose-insulin regulation characterizes effects of physical activity and facilitates personalized treatment evaluation in children and adults with type 1 diabetes. PLoS Computational Biology. 19(2). e1010289–e1010289. 8 indexed citations

Smit, Cornelis, Samira Samiee‐Zafarghandy, Sinno H. P. Simons, et al.. (2022). Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?. Neonatology. 120(1). 81–89. 4 indexed citations

10.

Burckhardt, Marie‐Anne, et al.. (2022). Semimechanistic modeling of copeptin and aldosterone kinetics and dynamics in response to rehydration treatment for diabetic ketoacidosis in children. CPT Pharmacometrics & Systems Pharmacology. 12(2). 207–220. 1 indexed citations

11.

Koch, Gilbert, et al.. (2022). Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care—Application to Neonatal Jaundice. Frontiers in Pharmacology. 13. 842548–842548. 4 indexed citations

12.

Dao, Kim, Aline Fuchs, Pascal André, et al.. (2021). Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation. Journal of Antimicrobial Chemotherapy. 77(2). 457–465. 3 indexed citations

13.

Burckhardt, Marie‐Anne, Verena Gotta, Katharina Rentsch, et al.. (2021). Aldosterone and pro-atrial natriuretic peptide kinetics in response to rehydration in children with diabetic ketoacidosis. 94. 1 indexed citations

14.

Koch, Gilbert, Stéphanie Leroux, Verena Gotta, et al.. (2021). Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study. Journal of Pharmacokinetics and Pharmacodynamics. 48(5). 711–723. 2 indexed citations

15.

Smit, Cornelis, Daniela Hofmann, Somphou Sayasone, Jennifer Keiser, & Marc Pfister. (2021). Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen. Clinical Pharmacokinetics. 61(1). 123–132. 6 indexed citations

16.

Leroux, Stéphanie, Valérie Biran, John van den Anker, et al.. (2021). Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates. Frontiers in Pharmacology. 12. 634686–634686. 5 indexed citations

17.

Wilbaux, Mélanie, et al.. (2018). Personalized weight change prediction in the first week of life. Clinical Nutrition. 38(2). 689–696. 13 indexed citations

18.

Zhang, Ping, Chee M. Ng, James F. List, & Marc Pfister. (2010). Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism‐Based Model Characterizing Sodium‐Glucose Cotransporter‐2 Inhibition. The Journal of Clinical Pharmacology. 50(S9). 113S–120S. 6 indexed citations

19.

Leil, Tarek A., et al.. (2010). Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose. Clinical Pharmacology & Therapeutics. 88(3). 375–382. 76 indexed citations

20.

Pfister, Marc, et al.. (1999). Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis. British Journal of Clinical Pharmacology. 47(6). 645–651. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact